Blog

This is tagline here

Begbroke Science Park > News and Press > Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference
Please set your featured image

Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference

Prosensa LogoCureDuchenne and Prosensa Holding N.V. (NASDAQ: RNA) have been selected to present at the 6th annual Partnering for Cures, November 16-18 in New York City. Convened by FasterCures, the Washington, D.C.-based center of the Milken Institute, the conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D. CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, and Prosensa, the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, will present “Accelerating Access to Treatments of Duchenne Muscular Dystrophy” on November 17.  Netherlands-based , Prosensa opened an Oxford office at the Begbroke Science Park in 2010.The presentation will focus on CureDuchenne and Prosensa’s $7 million (€5M) collaboration.

Joanna Grant